Previous studies have reported that potato carboxypeptidase inhibitors can inhibit the proliferation of pancreatic cancer by acting as a competitive inhibitor of epidermal growth factor (EGF) and by binding to EGFR [40]. The gene discussed is EGFR; the disease is familial pancreatic carcinoma.